CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy President & CEO bought 97,561 shares at $2.05 ($200,000)
- 4 Open-market buy Director bought 975,610 shares at $2.05 ($2,000,001)
- 4 Option exercise Director acquired 7,142 shares (option exercise)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 18,645 shares (grant or award)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
Page 3 of 16 · 315 filings